Sources | Names Used |
---|---|
CTRPv2 | BRD9876:MK-1775 (4:1 mol/mol) |
PharmacoGx | BRD9876:MK-1775 (4:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ZFX | CTRPv2 | pan-cancer | AAC | 0.23 | 0.04 |
mRNA | MAFB | CTRPv2 | pan-cancer | AAC | 0.27 | 0.04 |
mRNA | SMU1 | CTRPv2 | pan-cancer | AAC | 0.25 | 0.04 |
mRNA | PSMG3 | CTRPv2 | pan-cancer | AAC | 0.25 | 0.04 |
mRNA | AC104532.2 | CTRPv2 | pan-cancer | AAC | -0.22 | 0.04 |
mRNA | GMNN | CTRPv2 | pan-cancer | AAC | 0.23 | 0.04 |
mRNA | C15orf61 | CTRPv2 | pan-cancer | AAC | 0.25 | 0.04 |
mRNA | XPO4 | CTRPv2 | pan-cancer | AAC | 0.24 | 0.04 |
mRNA | SAMD14 | CTRPv2 | pan-cancer | AAC | 0.25 | 0.04 |
mRNA | PAIP2 | CTRPv2 | pan-cancer | AAC | 0.25 | 0.04 |